In a new study, researchers at Karolinska Institutet have identified the presence of a specific connection between a protein and an lncRNA molecule in liver...
Read More »lncRNA NEWS
Featured lncRNA Job – Scientist – RNA Biology
HAYA Therapeutics is a precision therapeutics company that discovers and develops innovative tissue- and cell-selective genomic medicines for fibrotic diseases and other serious health...
Read More »lncRNA identified as potential new diagnostic and therapeutic target for lung cancer
Scientists recently reported the key role of histone acetylation-regulated long noncoding RNA termed as lysosome cell death regulator (LCDR) in tumor survival, providing a potential diagnostic and therapeutic target for lung cancer.Led by Prof. GAO Shan...
Read More »RNA molecules with no apparent function represent a new therapeutic approach against fungal infection by Candida
Fungi of the Candida genus cause diseases such as vaginal candidiasis (highly prevalent but not serious) and systemic candidiasis (rare but can be fatal in immunocompromised patients). Although some...
Read More »RNAging: An exercise-regulated long noncoding RNA counteracts muscle aging
Skeletal muscle displays remarkable plasticity upon exercise, but is at the same time one of our organs that is most affected by aging. Skeletal muscle aging is characterized by estimated yearly losses of ~1% muscle mass and ~3% muscle strength in the elderly...
Read More »Machine learning analysis of long non-coding RNAs reveals new prognostic cancer biomarkers
Catalogue of 166 biomarkers generated through machine learning analysis of long non-coding RNAs A new batch of prognostic cancer biomarkers have...
Read More »New strategy against treatment-resistant prostate cancer identified
A study from Washington University School of Medicine in St. Louis has identified an long non-coding RNA molecule that suppresses prostate tumors...
Read More »Featured lncRNA Events
Jobs
-
Featured lncRNA Job – Scientist – RNA Biology
HAYA Therapeutics is a precision therapeutics company that discovers and develops innovative tissue- and cell-selective genomic medicines for fibrotic diseases and other serious health...
Read More » -
Postdoc position available – lncRNA, CRISPR & cancer in France
-
Featured lncRNA Jobs
-
Post-doc position available – Long noncoding RNA associated with chronic inflammation and cardiometabolic disease
-
Post-doc Position Available – Functional Validation of Long Noncoding RNA Associated with Autoimmunity
Industry News
-
APIS Assay Technologies and Moffitt Cancer Center sign Master Collaboration Agreement on lncRNA TROLL Biomarker assessment
APIS Assay Technologies Ltd. has entered into a Research & Development agreement with the Laboratory of Elsa Flores, Ph.D., and Marco Napoli, Ph.D. characterising the suitability of TROLL-2 and TROLL-3 as predictive biomarkers of cancer progression...
Read More » -
Dermtech’s lncRNA-based pigmented lesion assay (pla) receives medicare coverage
-
Abivax Treats First Patient in Phase 2a Rheumatoid Arthritis Clinical Trial of ABX464
-
BARD1 Life Sciences granted US patent for regulation of BARD1 expression by long non-coding RNA
-
Bio-Rad launches a RT-qPCR workflow optimized for long noncoding RNA discovery and validation